U.S. Biotech Stock News

Dividend announcement puts Xenia Hotels & Resorts (XHR) payout under the spotlight Xenia Hotels & Resorts (XHR) has declared a quarterly cash dividend of US$0.14 per share, with a March 31, 2026 ex-dividend date. This has drawn attention to its payout ratio and dividend sustainability. See our latest analysis for Xenia Hotels & Resorts. The latest quarterly dividend lands at a time when the share price has climbed to US$14.81, with a 1-year total shareholder return of 57.17% and a 3-month...

Leadership shift in business owner segment AllianceBernstein Holding (AB) is in focus after its private wealth arm expanded Kim Mustin’s role to lead the Business Owner segment nationally, highlighting this client group as a key area of emphasis. See our latest analysis for AllianceBernstein Holding. That leadership shift comes as the stock trades at US$38.63, with a 7 day share price return of 8.33% and a 1 year total shareholder return of 16.12%, pointing to firm but measured momentum...

EACO (EACO) has just posted its Q2 2026 numbers, with recent quarterly revenue running between about US$93.9 million and US$122.5 million and basic EPS ranging from US$1.33 to US$1.95 over the last six reported quarters. Trailing twelve month revenue sits at US$445.0 million and EPS at US$7.13. Over that same trailing period, earnings grew 73.4% year over year and net profit margin reached 7.8% compared with 5.4% a year earlier, setting the backdrop for investors to evaluate how sustainable...

If you are wondering whether Edwards Lifesciences is attractively priced or not, the key is to separate the share price story from the underlying value story. The stock last closed at US$81.05, with returns of 2.2% over 7 days, a 3.4% decline over 30 days, a 5.0% decline year to date, but a 16.9% gain over the past year that may catch your eye. Recent coverage has focused on how Edwards Lifesciences fits into longer term themes in medical devices and investor sentiment toward the broader...

If you are wondering whether Williams Companies is priced attractively right now, it helps to start by looking at how the current market value lines up against the business fundamentals. The stock last closed at US$72.00, with a 7 day return of a 2.1% decline, a 30 day return of a 3.7% decline, and longer term returns of 18.3% year to date and 36.3% over the past year, with a very large 5 year gain of 286.5% adding important context. Recent price moves sit against ongoing interest in US...

Why Sidus Space Stock Is Back on Investors’ Radar Sidus Space (SIDU) is drawing fresh attention after reporting full year 2025 results, with revenue of US$3.38 million and a net loss of US$29.47 million, alongside a pending 10 K filing. See our latest analysis for Sidus Space. That earnings update and the delayed 10 K have come alongside sharp share price swings, with a 1 day share price return of 47.14% and a 30 day share price return of 52.97%. This contrasts with a 90 day share price...

In recent sessions, Everpure Inc reported a strong uplift in market interest as analysts raised their earnings forecasts and projected a substantial year-on-year increase in next-quarter earnings per share. This shift in expectations highlights how quickly sentiment can strengthen when analysts reassess a company’s near-term business trends and profit potential. With analysts revising earnings estimates upward, we’ll now examine how this changing outlook could influence Everpure’s broader...

If you are wondering whether O'Reilly Automotive is priced attractively right now, it helps to step back and look at what the recent share performance and valuation checks are really telling you. The stock last closed at US$91.42, with returns of 1.5% over 7 days, a 3.1% decline over 30 days, a 1.2% gain year to date, and a 1.3% decline over the past year, sitting against much stronger 3 year and 5 year returns of 59.2% and 165.4%. Recent attention on O'Reilly Automotive has focused on how...

In recent days, GPGI has come under scrutiny after a short-seller report alleged accounting irregularities and inflated results at its newly acquired Husky Technologies unit, coinciding with the departures of Husky’s CEO and CFO and a quarterly update showing weaker revenue and higher net losses than a year earlier. This combination of disputed financial reporting, leadership turnover, and deteriorating performance at a key acquisition raises deeper questions about GPGI’s governance, risk...

Beam Therapeutics (BEAM) just cleared an important clinical hurdle, with Phase 1/2 BEACON trial results for its sickle cell therapy risto cel published in The New England Journal of Medicine. See our latest analysis for Beam Therapeutics. At a share price of US$24.66, Beam’s recent news around risto cel and BEAM-302 comes after a mixed stretch. A 1-day share price return of 1.82% and 7-day share price return of 11.13% contrast with a 90-day share price return of 9.14% and a 5-year total...

Lockheed Martin's Orion spacecraft for NASA's Artemis II mission has launched successfully with astronauts aboard. The mission marks the first crewed return to the Moon in over 50 years. New safety, life support, and communications systems from Lockheed Martin are being used in a deep space environment. The launch reinforces Lockheed Martin's role as a lead contractor for NASA and its position in future lunar programs. For investors watching NYSE:LMT, Artemis II highlights Lockheed Martin's...

DLocal recently reported a sharp year-over-year drop in adjusted EBITDA and contracting gross margins, citing a renegotiated contract with a key customer and currency devaluations in emerging markets, and management signaled full-year results are likely to land at the lower end of prior guidance. This combination of weaker profitability and a more cautious outlook highlights how sensitive DLocal’s business is to individual client terms and macroeconomic volatility in its core markets. Next,...

Concentrix (CNXC) has drawn fresh attention after first quarter revenue reached US$2,500.39 million and net income came in at US$21.59 million, alongside new guidance for second quarter and full year 2026 revenue and operating income. See our latest analysis for Concentrix. Despite the recent earnings update, Concentrix’s 1-day and 7-day share price returns of 2.63% and 3.22% sit against a 30-day share price return decline of 20.96% and a 1-year total shareholder return decline of 41.84%...

If you are wondering whether Sezzle's current share price offers value or is running ahead of itself, it helps to step back and look at what recent returns and fundamentals are actually saying. Over the past year the stock has returned 122.2%, with a 3.5% gain over the last 7 days. However, this sits alongside a 15.9% decline over the last 30 days and a year-to-date return of a 2.1% decline, which may hint at shifting views on its risk and reward profile. Recent news coverage has focused on...

For investors considering whether First Financial Bancorp at about US$28.08 is still good value or starting to look fully priced, this article walks through what the current market price might be implying about the stock. The share price sits around US$28.08, with returns of 3.0% over 7 days, 1.2% over 30 days, 11.9% year to date and 31.9% over the past year. This naturally raises questions about how much of the story is already priced in. Recent news flow around regional banks has kept...

In late March 2026, Bristol Myers Squibb reported that its Phase 3 SCOUT-HCM trial of Camzyos in adolescents with symptomatic obstructive hypertrophic cardiomyopathy met its primary endpoint, delivering a clinically meaningful and statistically significant reduction in Valsalva LVOT gradient and supportive safety data versus placebo over 28 weeks. The findings, showcased at the American College of Cardiology 2026 meeting and published in The New England Journal of Medicine, highlight...

Bilibili (BILI) is set to retire its long running "Guess You Like" recommendation system and roll out a new algorithm, a platform shift that could influence how users discover and spend time on content. See our latest analysis for Bilibili. Recent trading reflects a mixed picture, with a 7-day share price return of 3.2% and a 30-day share price return showing a decline of about 10%, while the 1-year total shareholder return stands at roughly 39%, indicating positive longer-term momentum...

In late March 2026, Cadence Design Systems reported past quarters of revenue and earnings ahead of expectations, backed by a record backlog and strong demand for its AI-enabled IP and core EDA tools, while analysts projected continued double-digit earnings growth heading into its fiscal Q1 2026 results. Alongside this financial momentum, Cadence’s inclusion on multiple “Best Workplaces” lists and its US$50.00 million commitment to addressing racial wealth inequality highlighted a workplace...

Wondering if PepsiCo at around US$157 a share looks like value or just a safety trade? This breakdown is designed to help you make sense of the current price. The stock has returned 2.6% over the last 7 days, while the 30 day return is a 2.3% decline, with year to date and 1 year returns of 10.4% and 11.4% respectively, giving you mixed signals on recent momentum and risk. Recent headlines have focused on PepsiCo's position as a major global food and beverage group and how it fits into...

TopBuild Corp (BLD) is back in focus after Wells Fargo added the insulation and building products company to its Q2 Tactical Ideas List, alongside a leadership shift that promoted John Achille to President and Chief Operating Officer. See our latest analysis for TopBuild. Despite a recent 1 month share price return decline of 12.58% and a 90 day share price return decline of 17.28%, TopBuild’s 1 year total shareholder return of 17.76% and 3 year total shareholder return of 86.41% point to...

On 25 March 2026, FormFactor, Inc. and Rohde & Schwarz announced a co-marketing partnership under the MeasureOne program to deliver validated, turnkey on-wafer RF test systems that integrate FormFactor’s probing platforms with Rohde & Schwarz’s vector network analyzers, signal analyzers, and generators up to the THz range. This collaboration creates an integrated workflow that can help chipmakers detect RF device issues at the wafer stage, potentially lowering test integration effort,...

ERP disruption and legal scrutiny put Tennant (TNC) in focus Tennant (TNC) recently reported severe problems with its new North American ERP system, disrupting orders, shipments, and customer service and contributing to a sharp drop in 2025 net income and sales. The disclosure has also attracted shareholder rights and law firms, which are examining whether earlier company statements about the ERP rollout accurately reflected the operational and financial risks investors were taking on. See...

In March 2026, Full Truck Alliance reported its Q4 and full-year 2025 results, with net income rising 42.8% year over year and transaction service revenues up 38.2%, while highlighting progress in deploying AI across its logistics platform. A key development was the commercial rollout of its Giga AI heavy truck fleet and pilot AI assistant tools aimed at improving fulfillment efficiency across the network. We’ll now examine how this AI-led operational progress and JPMorgan’s neutral rating...

Why SiriusPoint (SPNT) Is On Investors’ Radar SiriusPoint (SPNT) has drawn fresh attention after recent share price moves, with the stock closing at $22.19 and showing positive total returns over the past month and over the past three months. See our latest analysis for SiriusPoint. The recent 6.6% 7 day share price return and 5.3% 90 day share price return sit alongside a 38.3% 1 year total shareholder return and a 170% 3 year total shareholder return, suggesting momentum has been building...